Related Experiment Videos
[Congenital and perinatal infections]
M M Mussi-Pinhata1, A Y Yamamoto
1Hospital das Clínicas, Universidade de São Paulo (USP), São Paulo, SP, Brazil.
Jornal De Pediatria
|December 20, 2003
Summary
Congenital and perinatal infections affect up to 10% of newborns, with significant implications in Brazil. Early diagnosis and prevention are key, as treatments offer limited success for infected infants.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Congenital and perinatal infections pose a significant health risk to newborns globally and in Brazil.
- These infections can lead to severe long-term sequelae in infants, with many remaining asymptomatic at birth.
- Key pathogens include *T. pallidum*, hepatitis B virus, human immunodeficiency virus (HIV), cytomegalovirus (CMV), and *T. gondii*.
Purpose of the Study:
- To review current knowledge on congenital and perinatal infections.
- Focus on epidemiology in Brazil, mother-to-infant transmission, diagnosis, treatment, and prevention strategies.
- Evaluate specific agents like *T. pallidum*, HBV, HIV, CMV, and *T. gondii*.
Main Methods:
- Systematic review of published literature from the past 10 years.
- Electronic database search using Medline.
- Inclusion of studies focusing on epidemiology, transmission, diagnosis, treatment, and prevention.
Main Results:
- Congenital or perinatal infections occur in up to 10% of newborns.
- Brazilian data, though limited, highlight the relevance of infections by *T. pallidum*, HIV, and CMV.
- Over 50% of infected newborns are asymptomatic, underscoring the need for early detection.
- Advanced laboratory methods, including IgA/IgM antibody detection and PCR, enable early fetal/neonatal diagnosis.
- Current treatments show limited efficacy in altering infant prognosis.
Conclusions:
- Congenital and perinatal infections represent a substantial public health concern.
- Significant advancements have been made in preventive measures and laboratory diagnostic techniques.
- Further research into novel treatments and outcome studies is crucial for improving infant prognosis.